BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 38554444)

  • 1. Activation of SIRT1/Nrf2/HO-1 and Beclin-1/AMPK/mTOR autophagy pathways by eprosartan ameliorates testicular dysfunction induced by testicular torsion in rats.
    Abu-Baih RH; Abu-Baih DH; Abdel-Hafez SMN; Fathy M
    Sci Rep; 2024 May; 14(1):12566. PubMed ID: 38822026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One anastomosis gastric bypass ameliorates diabetic nephropathy via regulating the GLP-1-mediated Sirt1/AMPK/PGC1α pathway.
    Han L; Chen X; Wan D; Xie M; Ouyang S
    Clin Exp Nephrol; 2024 May; ():. PubMed ID: 38782822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BM-MSCs alleviate diabetic nephropathy in male rats by regulating ER stress, oxidative stress, inflammation, and apoptotic pathways.
    Khamis T; Abdelkhalek A; Abdellatif H; Dwidar N; Said A; Ahmed R; Wagdy K; Elgarhy R; Eltahan R; Mohamed H; Said Amer E; Hanna M; Ragab T; Kishk A; Wael J; Sarhan E; Saweres L; Reda M; Elkomy S; Mohamed A; Samy A; Khafaga A; Shaker Y; Yehia H; Alanazi A; Alassiri M; Tîrziu E; Bucur IM; Arisha AH
    Front Pharmacol; 2023; 14():1265230. PubMed ID: 38044936
    [No Abstract]   [Full Text] [Related]  

  • 4. Ameliorative effect of Metformin / alpha-lipoic acid combination on diabetic nephropathy via modulation of YAP/ miR-29a/PTEN/p-AKT axis.
    Helmy SA; Nour OA; G Abd El Salam AS
    Int Immunopharmacol; 2024 May; 135():112294. PubMed ID: 38776856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy.
    Williquett J; Allamargot C; Sun H
    Kidney360; 2024 Apr; 5(4):538-549. PubMed ID: 38467599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-nephritic activity of a polysaccharide from okra (Abelmoschus esculentus (L.) Moench) via modulation of AMPK-Sirt1-PGC-1α signaling axis mediated anti-oxidative in type 2 diabetes model mice.
    Liao Z; Zhang J; Wang J; Yan T; Xu F; Wu B; Xiao F; Bi K; Niu J; Jia Y
    Int J Biol Macromol; 2019 Nov; 140():568-576. PubMed ID: 31442509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on the inhibitive effect of Catalpol on diabetic nephropathy.
    Chen J; Yang Y; Lv Z; Shu A; Du Q; Wang W; Chen Y; Xu H
    Life Sci; 2020 Sep; 257():118120. PubMed ID: 32693244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
    Li F; Chen Y; Li Y; Huang M; Zhao W
    Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isorhapontigenin ameliorates high glucose-induced podocyte and vascular endothelial cell injuries via mitigating oxidative stress and autophagy through the AMPK/Nrf2 pathway.
    Tian H; Zheng X; Wang H
    Int Urol Nephrol; 2023 Feb; 55(2):423-436. PubMed ID: 35960477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats.
    Eisa NH; Khodir AE; El-Sherbiny M; Elsherbiny NM; Said E
    Biomed Pharmacother; 2021 Oct; 142():111666. PubMed ID: 34215478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmine alleviated STZ-induced rat diabetic nephropathy: A potential role via regulating AMPK/Nrf2 pathway and deactivating ataxia-telangiectasia mutated (ATM) signaling.
    Tabaa MME; Tabaa MME; Rashad E; Elballal MS; Elazazy O
    Int Immunopharmacol; 2024 May; 132():111954. PubMed ID: 38554444
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.